Corvus Pharmaceuticals, Inc. (CRVS) Earnings
NASDAQ·Healthcare·Biotechnology
$10.54
+0.72%
Mkt Cap $886.63M
EPS — Estimate vs Actual
Mkt Cap
$886.63M
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$0.55
NASDAQ·Healthcare·Biotechnology
$10.54
+0.72%
Mkt Cap $886.63M
Mkt Cap
$886.63M
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$0.55